Full-Time

Product Manager Medical Devices

Posted on 12/13/2025

Novanta

Novanta

1,001-5,000 employees

Provides core photonics for medical tech

No salary listed

Berlin, Germany

In Person

International travel up to 20%; passport required.

Category
Product (1)
Requirements
  • Broad and deep functional experience. Typically acquired through 5 to 8 years of relevant work experience ideally in product management for medical devices.
  • Requires extensive research, in-depth knowledge and creativity.
  • Requires that complex problems are anticipated, identified, defined and resolved. Recommendations made by others are analyzed to solve issues bearing broad and long-term impact.
  • Complex and varied problem-solving requires extensive diagnosis. Incumbent acts as advisors to less-experienced personnel. Required to train others. Exercises primarily technical and some process leadership.
  • Work requires advanced knowledge of several specific fields of knowledge related to one of the company’s major business functions or of customer’s business requirements, specialized knowledge of product design and process management methods is also needed.
  • Travel by public transportation including train and airplane on demand (max 10-20 %)
  • Passport for international travel (customer & internal meetings)
Responsibilities
  • Retrieve and analyse feedback from customers٫ stakeholders and other teams to shape customer requirements٫ features and end products
  • Accountability for revenue & gross margin for a product or product group
  • Create product concepts, plans and roadmaps for next generation products, and build product strategies consistent with company vision
  • Create and own NPVs and contribute to phase gate process
  • Prepare and review product requirements documents
  • Support Upstream / Marketing for Value Proposition, Pricing, Product Positioning and Mid-term Portfolio Strategy
  • Collaborate with Upstream Marketing to build business cases for New Product Introduction
  • Perform product validation in a laboratory and clinical setting
  • Clinical indication and application knowledge in Minimal Invasive Surgery
  • Manage product changes and discontinuations with Key Account Management
  • Coordinate cross-functional teams and collaborate with customers, upstream / marketing, sales and R&D
  • Executing Product Lifecycle management and competition analysis
  • Contribution and support of risk management process
  • Coordination of sustaining activities and PM-related Regulatory Processes as Clinical Evaluation, Post Market Surveillance, Post Market Clinical Follow-up, Usability
  • Act as a Medical product consultant

Novanta designs and supplies core technology platforms for precision photonics used in medical devices and advanced industrial equipment. Its products are components and subsystems—such as lasers, optics, sensors, and imaging hardware—that OEMs integrate into their own machines. Unlike companies that sell end-user devices, Novanta focuses on providing the underlying photonics technology that OEMs build into products, enabling reliable performance and scalable manufacturing. The company differentiates itself through deep specialization in photonics and by growing through acquisitions, aligning its portfolio toward medical technology and precision industrial markets. Its goal is steady, long‑term growth by delivering proven core technologies that help customers develop better medical devices and industrial solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bedford, Texas

Founded

1968

Simplify Jobs

Simplify's Take

What believers are saying

  • Medical technology now 53% of revenue with double-digit consumables growth trajectory.
  • $1.5 billion acquisition capacity targeting medical technologies and bioprocessing markets.
  • 25% bookings surge in Q4 2025 across all business units signals demand recovery.

What critics are saying

  • Intuitive Surgical integrates in-house components, displacing Novanta drives in 40% of designs.
  • Manufacturing transfers create 100 basis point margin compression through Q2 2026.
  • Overreliance on medical tech exposes company to Intuitive Surgical supply chain diversification.

What makes Novanta unique

  • Sole-source supplier of precision motion control for high-density GPU board drilling.
  • Integrated portfolio of motion, vision, and force-sensing for surgical robotics.
  • Strategic board seat in Health Lean Analytics for AI-powered hospital data automation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Performance Bonus

Company News

Yahoo Finance
Mar 26th, 2026
Novanta falls 17% after revenue miss in otherwise strong Q4 for electronic components sector

As Q4 earnings season concludes, the nine electronic components stocks tracked showed strong performance, with revenues beating analyst consensus estimates by 3%. Share prices rose 5.2% on average since results were announced. Novanta posted revenues of $258.3 million, up 8.5% year-on-year, but fell short of analyst expectations by 0.9%. The company delivered the weakest performance against estimates in the group, with significant EBITDA misses. Its stock has dropped 17.4% since reporting, currently trading at $117.59. Allient led the group, reporting revenues of $143.4 million, up 17.5% year-on-year and beating expectations by 7.5%. The company also exceeded EBITDA estimates. Its shares have risen 6.3% since reporting, trading at $66.01.

EU-Startups
Mar 18th, 2026
Barcelona's Health Lean Analytics raises over $2.4M to automate hospital data with AI

Health Lean Analytics, a Barcelona-based startup automating hospital data collection, has raised over €2.1 million in a financing round combining private capital and public funding. US-listed Novanta joined as a technology and strategic partner, securing board representation. The round included an oversubscribed €1.4 million seed funding from family offices Inderhabs, Namarel and Braincats, plus a participative loan from Spain's National Innovation Company. Founded in 2023, HLA develops AI-powered hospital operations platforms that passively capture real-time clinical and operational data, particularly in surgical suites. The startup's technology integrates with existing hospital systems, using large language models to transform data into actionable insights. The funding will support domestic consolidation and US market entry within 12 months, whilst strengthening R&D capabilities in data automation and AI.

Yahoo Finance
Mar 4th, 2026
Harvey Partners bets $36M on Novanta despite flat stock performance

Harvey Partners disclosed a new position in Novanta, acquiring 304,000 shares worth $36.17 million during the quarter ending 17 February 2026, according to an SEC filing. The stake now represents 3.21% of the fund's reportable assets under management. Novanta, which provides photonics, vision and precision motion components for medical and industrial applications, has seen its shares remain roughly flat over the past year at around $145, significantly underperforming the S&P 500's 16% gain. The company reported revenue of $980.6 million in 2025, up 3% year over year, but operating income fell to $94 million from $110.6 million, whilst net income dropped from $64.1 million to $53.8 million. CEO Matthijs Glastra said the company plans to improve margins and cash flow this year.

Yahoo Finance
Feb 26th, 2026
Novanta CEO sells $1.1M worth of shares under pre-arranged trading plan

Novanta CEO Matthijs Glastra sold 7,500 common shares worth approximately $1.09 million on 10 February 2026, according to an SEC Form 4 filing. Following the transaction, Glastra holds 57,367 shares directly and 54,382 shares indirectly through a trust, with direct holdings valued at $8.3 million. The sale was executed under a pre-established Rule 10b5-1 trading plan adopted in September 2025, indicating routine liquidity management rather than concerns about company performance. The transaction matches Glastra's largest trade size in his 10 sell-only transactions since February 2023. Novanta manufactures photonics, vision and precision motion components for medical and industrial sectors, reporting $960.31 million in trailing twelve-month revenue and employing 3,000 people.

Yahoo Finance
Feb 24th, 2026
Novanta posts record Q4 on 25% bookings surge, targets $1.5B medical tech M&A

Novanta Inc. reported record fourth-quarter revenue and a return to organic growth, driven by a 25% surge in bookings across all business units. The precision technology company benefited from AI-driven demand in robotics, serving as the sole-source supplier for precision drilling of high-density GPU boards. Medical technology now represents 53% of total sales, with double-digit growth in consumables. However, the company experienced margin pressure due to regional manufacturing transfers, creating a temporary 100 basis point headwind. For 2026, Novanta projects mid-single-digit organic growth and 100 basis points of gross margin expansion once manufacturing transfers complete by Q2. The company plans to deploy nearly $1.5 billion in acquisition capacity towards medical technologies and bioprocessing. Operating cash flow is forecast at $145 million to $185 million.

INACTIVE